Naperville, IL — August 27, 2025 /OrthoSpineNews/ — Joint Preservation Innovations, LLC (JPI), a pioneering orthopedic medical device company focused on redefining minimally invasive surgical solutions, announced today the official submission of its 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for its flagship device, the Arthroscopic Articulator™ Bur.
This milestone represents a pivotal step in JPI’s mission to transform the way orthopedic surgeons perform bone resection in tight joint spaces, beginning with arthroscopic procedures of the hip, shoulder and other joints. The Articulator™ is the first tool of its kind – a precision-engineered, articulating rotary cutting instrument that offers unprecedented maneuverability, visualization, and efficiency during minimally invasive procedures.
“Our 510(k) submission marks the culmination of years of surgeon-led design, iterative prototyping, and rigorous testing,” said Sanjeev Bhatia, MD, CEO and Co-Founder of Joint Preservation Innovations. “The Articulator™ is not just a device – it’s a platform technology that empowers surgeons to achieve what was previously difficult or impossible in tight joint spaces. Our goal is to enable more anatomic resections through smaller portals, reduce collateral damage to healthy tissue, and ultimately drive better patient outcomes.”
The Articulator™ is designed to be adapted across a wide range of orthopedic and spinal procedural applications. The company has 15 granted patents which protect its core technology in a variety of endoscopic, spinal and robotic uses. In 2023, the company was awarded the coveted FDA Breakthrough Device Designation status. Future iterations of Articulator™ technology are already in development for:
- Endoscopic Spinal procedures, including central, ipsilateral and contralateral decompression
- Robotic-assisted orthopedic and spinal procedures, where articulation adds surgical versatility within constrained anatomical corridors
About Joint Preservation Innovations
Joint Preservation Innovations, LLC is a privately held medical device company based in Naperville, IL. Founded by orthopedic surgeons, biomedical engineers and business leaders, JPI is dedicated to advancing the frontiers of minimally invasive orthopedic surgery through surgeon-inspired innovation. The company’s flagship product, the Articulator™ Bone Resection Platform, is poised to become a foundational technology across multiple orthopedic subspecialties.
From idea to execution, JPI emphasizes clinical relevance, manufacturing efficiency, and regulatory compliance – ensuring that every device is purpose-built for real-world surgical challenges. With a pipeline of complementary products in development, JPI’s long-term vision is to build a portfolio of high precision, articulating tools that redefine what’s possible in minimally invasive surgery.
Media Contact:
Investor Relations
Joint Preservation Innovations, LLC
IR@joint-innovations.com
Website: www.joint-innovations.com
